Heart disease is the leading cause of death in America, accounting for about 1 in 4 fatalities each year. This sobering statistic has remained largely unchanged for decades within populations of color, particularly for Black Americans. To help uncover how we’ve arrived at this point and where to go from here, the Medical Alley Association…

The Heart Failure Society of America (HFSA) is hosting a virtual program of education and support for heart failure patients and caregivers. The program will give patients and caregivers the opportunity to participate in interactive educational sessions with the leading experts in the field. The objectives of the Heart Failure Patient and Caregiver Day are…

HoFH is a genetic disorder of lipid metabolism resulting in severely elevated LDL-C and early onset ASCVD and increased CV events and mortality. Individuals with HoFH are typically less responsive, or even unresponsive, to standard lipid-lowering therapies such as statins and PCSK9 inhibitors, and may benefit from treatment modalities with other mechanisms of action. This…